Literature DB >> 25912537

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample.

Leonardo Zaninotto1,2, Daniel Souery3, Raffaella Calati4, Giovanni Camardese1, Luigi Janiri1, Stuart Montgomery5, Siegfried Kasper6, Joseph Zohar7, Diana De Ronchi2, Julien Mendlewicz8, Alessandro Serretti2.   

Abstract

OBJECTIVE: The present study aims at exploring associations between a continuous measure of distorted thought contents and a set of demographic and clinical features in a sample of unipolar/bipolar depressed patients.
METHODS: Our sample included 1,833 depressed subjects. Severity of mood symptoms was assessed by the 21 items Hamilton Depression Rating Scale (HAM-D). The continuous outcome measure was represented by a delusion (DEL) factor, extracted from HAM-D items and including items: 2 ("Feelings of guilt"), 15 ("Hypochondriasis"), and 20 ("Paranoid symptoms"). Each socio-demographic and clinical variable was tested by a generalized linear model test, having depressive severity (HAM-D score?DEL score) as the covariate.
RESULTS: A family history of major depressive disorder (MDD; p=0.0006), a diagnosis of bipolar disorder, type I ( p=0.0003), a comorbid general anxiety disorder (p<0.0001), and a higher number of manic episodes during lifetime (p<0.0001), were all associated to higher DEL scores. Conversely, an older age at onset (p<0.0001) and a longer duration of hospitalization for depression over lifetime (p=0.0003) had a negative impact over DEL scores. On secondary analyses, only the presence of psychotic features (p<0.0001) and depressive severity (p<0.0001) were found to be independently associated to higher DEL scores.
CONCLUSIONS: The retrospective design and a non validated continuous measure for distorted thought contents were the main limitations of our study. Excluding the presence of psychotic features and depressive severity, no socio-demographic or clinical variable was found to be associated to our continuous measure of distorted thinking in depression.

Entities:  

Keywords:  Delusions; Depression; Dimensional model; Psychotic disorders

Year:  2015        PMID: 25912537      PMCID: PMC4423154          DOI: 10.9758/cpn.2015.13.1.48

Source DB:  PubMed          Journal:  Clin Psychopharmacol Neurosci        ISSN: 1738-1088            Impact factor:   2.582


INTRODUCTION

An increasing body of evidence suggests the superiority of dimensional over categorical models of psycho-pathology.1–3) Psychopathological dimensions are thought to express more suitable clinical phenotypes,4,5) and to have a much more identifiable biological basis.6,7) A dimensional approach may be particularly relevant for psychotic symptoms,8) such as delusional thinking and hallucinations. Indeed, psychotic experiences have been shown to exist across a symptomatic continuum in the general population.9) Furthermore, in psychiatric disorders there is a high degree of overlap between psychotic experiences and affective symptoms below the threshold for a clinical disorder.10–12) Thus, the notion of a continuum of psychosis may be particularly relevant to mood disorder patients, whose symptoms can span from common dysfunctional thoughts and negative attributions to delusional beliefs.13) The present study aims to explore, through multivariate analysis, any association between a continuous measure of delusional thinking and a set of demographic, anamnestic and psychopathological features in a sample of unipolar/bipolar depressed patients.

METHODS

Participants were recruited from two large study projects: 1) the “Patterns of treatment resistance and switching strategies in unipolar affective disorder” project, in the context of the Group for the Study of Resistant Depression (GSRD),14,15); and 2) Clinical Outcome and Psycho Education (COPE) program for Bipolar Disorder.16) Patients were included if they met the Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) diagnostic criteria for a mood disorder, including major depressive disorder (MDD); bipolar disorder, type I (BP-I); and bipolar disorder, type II (BP-II).17) Individuals with mental retardation, dementia, or severe organic diseases were excluded. The study protocol was approved by the ethics committees of all participating centers, and written informed consent was obtained from all participants. Current and lifetime diagnosis, course of illness and psychiatric comorbidities were assessed by specifically trained psychiatrists on the basis of a modified version of the Mini International Neuropsychiatric Interview (MINI) - version 5.0.0.18) Psychiatric familial antecedents and somatic comorbidities were also screened by clinical investigation using all available sources of information, including previous charts, family members and previous treating clinicians. Following the MINI-5.0.0 interview,18) all subjects meeting diagnostic criteria for a major depressive episode (MDE) at the intake were included in the final sample (n=1,833). Severity of mood symptoms was assessed at baseline by the 21 item Hamilton Depression Rating Scale (HAM-D).19) For the present study, a delusion (DEL) factor was extracted following a previous pooling of HAM-D items.20,21) DEL factor included items 2 (“Feelings of guilt”: scoring from 0=“No symptom” to 4=“Hears accusatory or denunciatory voices and/or experiences threatening visual hallucinations”), 15 (“Hypochondriasis”: scoring from 0=“No symptom” to 4=“Hypochondriac delusions”), and 20 (“Paranoid symptoms”: scoring from 0=“No symptom” to 3=“Delusions of reference and persecution”). DEL factor was explored as the continuous outcome variable, spanning from common dysfunctional thoughts and negative attributions to delusional beliefs. The accuracy and completeness of the clinical information collected were independently tested by two researchers. All raters were trained in the use of instruments with good inter-rater reliability (k>0.8). All statistical analyses were performed using Statistica package (Dell Software, Tulsa, OK, USA). A series of generalized linear model tests were performed to detect any individual effect on the outcome variable of 6 socio-demographic and 30 clinical variables. A measure of depressive severity (HAM-D score–DEL score) was used as the covariate. All significant variables in the previous models were considered as eligible predictors in a final generalized linear model having DEL as the dependent variable. In order to limit the number of predictors, levels of Pearson’s r (>0.40) were used to detect any strong correlation between continuous independent variables. All p values were 2-tailed, and statistical significance was conservatively set at the 0.001 level (0.05 divided by 6 socio-demographic and 30 clinical variables), also considering that the present sample has been previously investigated.14–16) A Bonferroni corrected α was adopted to adjust for multiple comparisons.

RESULTS

Sample features are described in Table 1. Regarding the impact of socio-demographic variables, gender, ethnic origin or civil status had no effect on DEL, while being older (Estimation [EST]=−0.004; standard error [SE]= 0.001; Wald= 11.491; p=0.001), employed (vs. student; Est=−0.112; SE=0.031; Wald=13.294; p=0.0003) and with no education (vs. high education; Est=−0.242; SE=0.070; Wald=12.051; p=0.0005) were all significantly and negatively correlated with DEL score. A family history of MDD in first degree relatives was associated to higher DEL scores (Est=0.056; SE=0.016; Wald=12.058; p=0.0006), while we did not find any effect of family history of BP or suicide.
Table 1

Socio-demographic and clinical variables of the sample (n=1,833)

Clinical variableData
Males562 (30.7)
Caucasians (vs. other)1,778 (97)
Age (yr)48.4±14.1
Civil status (n=1,684)
 Single459 (27.3)
 Married/cohabiting832 (49.4)
 Divorced/separated250 (14.8)
 Widowed143 (8.5)
Employment status (n=1,723)
 Employed1,439 (83.5)
 Unemployed150 (8.7)
 Retired88 (5.1)
 Student46 (2.7)
Level of education (n=1,760)
 None94 (5.3)
 Elementary338 (19.2)
 Intermediate796 (45.2)
 High532 (30.2)
Diagnosis
 MDD1,330 (72.6)
 BP-II147 (8.0)
 BP-I356 (19.4)
Family history
 MDD998 (54.4)
 BP247 (13.5)
 Suicide291 (15.9)
Illness course
 MDD, single episode426 (23.8)
 Last episode depressive1,540 (93.3)
 Last episode manic/hypomanic110 (6.7)
 Seasonal affective disorder275 (15.0)
Psychotic features Lt* (n=1,732)301 (17.4)
Features (feat.) of current MDE
 MDE with psychotic feat. (n=1,723)237 (13.8)
 MDE with melancholic feat. (n=1,767)1,135 (64.2)
 Double depression (n=1,713)74 (4.3)
 Presence of suicide risk (n=1,797)1,183 (65.8)
Comorbidities
 Somatic comorbidites1,019 (55.6)
 Psychiatric comorbidites897 (48.9)
 Anxiety disorders710 (38.7)
 Panic disorders401 (21.9)
 Social phobia (n=1,829)195 (10.7)
 OCD (n=1,814)122 (6.7)
 PTSD (n=1,831)95 (5.2)
 Generalized anxiety disorder308 (16.8)
 Substance use disorders224 (12.2)
 Drug use83 (4.5)
 Alcohol use (n=1,830)164 (9.0)
 Axis II (n=423)154 (36.4)
HAM-D score20.7±7.0

Values are presented as number (%) or mean±standard deviation. MDD, major depressive disorder; BP, bipolar disorder; BP-I, BP, type I; BP-II, BP, type II; Lt, lifetime; MDE, major depressive episode; OCD, obsessive-compulsive disorder; PTSD, post-traumatic stress disorder.

At least one mood episode (both depressive and manic) with psychotic features during lifetime.

Double depression is defined by a MDE accompanied by dysthymic disorder.

Being diagnosed as BP-I (vs. MDD; Est=0.094; SE=0.026; Wald=13.226; p=0.0003) and currently having a MDE with psychotic features (Est=0.303; SE=0.015; Wald=416.972; p<0.0001) were both associated to higher DEL scores. Otherwise, past psychotic symptoms, seasonal recurrence, melancholic features and double depression (dystimic disorder+MDE) resulted to have no effect. An older age at onset (Est=−0.005; SE=0.001; Wald=18.822; p<0.0001), an older age at the first MDE (Est=−0.004; SE=0.001; Wald=14.410; p=0.0001), and a longer duration of hospitalization for depression during lifetime (expressed in weeks; Est=−0.003; SE=0.0008; Wald=13.140; p=0.0003) had a negative impact over DEL score. Also, being an inpatient at the intake was associated with lower DEL scores (Est=−0.068; SE=0.015; Wald=19.166; p<0.0001). Conversely, a higher number of manic episodes was associated to higher DEL scores (Est=0.0184; SE=0.005; Wald=13.014; p<0.0001). Regarding comorbidites, we could detect a positive effect of anxiety disorders in general (Est=0.048; SE=0.015; Wald=9.645; p=0.0019), and generalized anxiety disorder (GAD) in particular (Est=0.101; SE=0.018; Wald=32.414; p<0.0001). No effect was found for panic disorder, social phobia, post-traumatic stress disorder, obsessive-compulsive disorder, alcohol use or substance use disorders. The presence of an Axis II disorder was associated to higher DEL scores (Est=0.156; SE=0.047; Wald=10.828; p=0.0010). A final generalized linear model was performed to test the effect of significant categorical and continuous variables on DEL score. Since lifetime duration of hospitalization for depression (weeks), age, age at the first MDE, and age at onset resulted to be reciprocally correlated (r≥ 0.4; p<0.0001), we only considered the latest variable for the final model. Thus, independent variables were: a) “Age at onset”; b) “Number of manic episodes during lifetime”; c) “Presence of Psychotic features (current)”; d) “Being employed” (vs. being student); e) “A diagnosis of BP-I” (vs. MDD)”; f) “A family history of MDD”; g) “A diagnosis of comorbid GAD”; h) “Being an inpatient (vs. outpatient); i) “Depressive severity” (HAM-D score–DEL score). After Bonferroni post-hoc correction (corrected α=0.0001), only the presence of psychotic features (Est=0.305; SE=0.019; Wald=256.936; p<0.0001) and depressive severity (Est=0.027; SE=0.003; Wald=86.952; p<0.0001) were found to be positively and independently associated to higher DEL scores.

DISCUSSION

The present study aims to provide an overall view of the effects of different socio-demographic and clinical variables on a continuous measure of depressive distorted thinking. Overall, our preliminary findings seem to sketch out the features which may be associated to more distorted thought contents during a depressive episode. A diagnosis of BP-I, a comorbid anxiety disorder (especially GAD), a younger age at onset, a shorter duration of hospitalization for depressive episodes, and a higher number of manic episodes during lifetime, were all associated to higher DEL scores. The importance of bipolarity on the emergence of psychotic features,22,23) and the higher frequency of mood episodes of psychotic affective disorders24–26) are both clearly defined. Nonetheless, our results indicate the significant role of mania27) in fostering the development of psychotic symptoms in depression. A recent study by Popovic et al.28) has shown that bipolar patients with a predominantly manic polarity presented a younger age at onset and a higher prevalence of BP-I diagnosis and psychotic symptoms. The fact that patients with a greater severity of dysfunctional beliefs are treated in an outpatient setting may be due to two factors : a) other variables (e.g., suicide risk) may be more important in guiding decisions on admission; and b) psychotic symptoms may be missed because of their tendency to be intermittent, less prominent, or concealed by the patient.29) After post-hoc correction, no significant anamnestic or clinical determinant other than depressive severity resulted to impact over the emergence of dysfunctional beliefs.13,25,30,31) Severity of depression has been proved to be associated with more severely distorted negative cognitions, which in turn may predict the emergence of psychotic symptoms,13) however this multivariate analysis may hide the clinical univariate correlations, therefore we reported both. A major strength of our study is that participants came from a non-specific clinical population, including both in-patients and outpatients. Most of our findings are easily detectable at a screening interview and with the most common rating scales for depression. The major limitation of this study is its retrospective design. Secondly, we did not account for the influence of previous pharmacotherapy on the clinical presentation of the patients’ current mood episodes. The psychopathological dimensions of DEL was constructed of scales which were not specifically designed for that purpose. The use of dimensional models of psychopathology in addition to categorical ones might be profitable in the future.32–35) Our study suggests that depressive severity may be the only significant determinant on the development dysfunctional thinking and delusions during a depressive episode.
  34 in total

1.  The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update.

Authors:  R Lieb; B Isensee; K von Sydow ; H U Wittchen
Journal:  Eur Addict Res       Date:  2000-12       Impact factor: 3.015

2.  Phenomenology of psychotic mood disorders: lifetime and major depressive episode features.

Authors:  Daniel Souery; Leonardo Zaninotto; Raffaella Calati; Sylvie Linotte; Othman Sentissi; Daniela Amital; Ulrike Moser; Siegfried Kasper; Joseph Zohar; Julien Mendlewicz; Alessandro Serretti
Journal:  J Affect Disord       Date:  2011-09-01       Impact factor: 4.839

3.  Early developmental stages of psychopathology study (EDSP): objectives and design.

Authors:  H U Wittchen; A Perkonigg; G Lachner; C B Nelson
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

4.  Neuroanatomic correlates of psychopathologic components of major depressive disorder.

Authors:  Matthew S Milak; Ramin V Parsey; John Keilp; Maria A Oquendo; Kevin M Malone; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2005-04

5.  Psychotic symptoms in non-clinical populations and the continuum of psychosis.

Authors:  Hélène Verdoux; Jim van Os
Journal:  Schizophr Res       Date:  2002-03-01       Impact factor: 4.939

6.  Dimensional approach to delusions in psychotic depression in the elderly: factor structure and clinical correlates.

Authors:  Rossetos Gournellis; Panagiotis Oulis; Panagiota Michalopoulou; Adamantia Kaparoudaki; Christos Dimitrakopoulos; Lefteris Lykouras
Journal:  Int J Geriatr Psychiatry       Date:  2009-04       Impact factor: 3.485

7.  Psychotic features in bipolar and unipolar depression.

Authors:  Fernando S Goes; Bradley Sadler; Jennifer Toolan; Rachel D Zamoiski; Francis M Mondimore; Dean F Mackinnon; Barbara Schweizer; J Raymond Depaulo; James B Potash
Journal:  Bipolar Disord       Date:  2007-12       Impact factor: 6.744

8.  Dysfunctional cognitions in hospitalized patients with psychotic versus nonpsychotic major depression.

Authors:  Brandon A Gaudiano; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2007-05-24       Impact factor: 3.735

Review 9.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

10.  Using dimensional models of externalizing psychopathology to aid in gene identification.

Authors:  Danielle M Dick; Fazil Aliev; Jen C Wang; Richard A Grucza; Marc Schuckit; Samuel Kuperman; John Kramer; Anthony Hinrichs; Sarah Bertelsen; John P Budde; Victor Hesselbrock; Bernice Porjesz; Howard J Edenberg; Laura Jean Bierut; Alison Goate
Journal:  Arch Gen Psychiatry       Date:  2008-03
View more
  3 in total

1.  Socio-demographic and clinical characterization of patients with Bipolar Disorder I vs II: a Nationwide Italian Study.

Authors:  A Carlo Altamura; Massimiliano Buoli; Bruno Cesana; Bernardo Dell'Osso; Gianluigi Tacchini; Umberto Albert; Andrea Fagiolini; Andrea de Bartolomeis; Giuseppe Maina; Emilio Sacchetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-01       Impact factor: 5.270

2.  Effect of lamotrigine in the treatment of bipolar depression with psychotic features: a case report.

Authors:  Tomoko Kajiya; Hiroko Sugawara; Yusuke Kajio; Satoru Morieda; Hibiki Tanaka; Tadashi Jono; Noboru Fujise; Mamoru Hashimoto
Journal:  Ann Gen Psychiatry       Date:  2017-08-09       Impact factor: 3.455

3.  Hypochondriac concerns and correlates of personality styles and affective states in bipolar I and II disorders.

Authors:  Bing Pan; Qing Zhang; Huitzong Tsai; Bingren Zhang; Wei Wang
Journal:  BMC Psychiatry       Date:  2018-12-22       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.